U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately
Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.
Why the vaccine safety numbers are still fuzzy
If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.
The FDA’s caution on the J&J vaccine is a costly mistake
The FDA acted after blood clots were observed in less than one in a million people who have received the J&J vaccine. COVID-19 has already killed 1,712 out of every million Americans.
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
J&J's vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier.
Johnson & Johnson vaccine highly effective against severe COVID-19 cases
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the U.S. Food and Drug Administration on Wednesday. The news came as the regulator was set to convene an independent panel Friday that will ...
Johnson & Johnson’s vaccine advances, sparking optimism in race
The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available. There are ...
J&J CEO says he didn't read internal documents on possible asbestos in Baby Powder
Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson's Baby Powder. It was the CEO's first appearance in a jury trial over allegations that the company's ...
Largest study yet offers no clear talc link to ovarian cancer
U.S. researchers who conducted the largest study yet into whether applying powder to the genitals increases a woman's risk of ovarian cancer were unable to definitively put to rest the issue that has prompted thousands of lawsuits against Johnson & Johnson and other companies. Overall, ...
